Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 We write to inform you that the Board of Directors of the Company at its meeting held on February 10, 2023 has, inter alia, approved the unaudited financial results for the quarter and nine months ended December 31, 2022 (Standalone and Consolidated) as enclosed. We are enclosing herewith the Limited Review Report dated February 10, 2023 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, S R B C & Co. LLP. Kindly take the above on record. The Board meeting commenced at 11.45 a.m. and concluded at 01.00 p.m.
10-02-2023
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

 We write to inform you that the Board of Directors of the Company at its meeting held on February 10, 2023 has, inter alia, approved the unaudited financial results for the quarter and nine months ended December 31, 2022 (Standalone and Consolidated) as enclosed. We are enclosing herewith the Limited Review Report dated February 10, 2023 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Company's Statutory Auditors, S R B C & Co. LLP. Kindly take the above on record. The Board meeting commenced at 11.45 a.m. and concluded at 01.00 p.m.
10-02-2023
Bigul

Fermenta Biotech Ltd - 506414 - Board Meeting Intimation for Notice Of Board Meeting And Closure Of Trading Window

 Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 ,inter alia, to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 10, 2023, inter alia, to consider and approve the unaudited financial results of the Company (standalone and consolidated) for the quarter and nine months ended December 31, 2022.
02-02-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited on January 31, 2023 regarding issue of duplicate share certificate to the shareholder.
31-01-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended December 31, 2022, we hereby certify that on receipt of securities for dematerialization - a. The securities comprised in the said certificate(s) of security have been listed on the stock exchanges where the earlier securities are listed; b. The said certificate(s) after due verification have been mutilated and cancelled and the name of the depositories have been substituted in the register of members as the registered owner. The above is confirmed based on the certificate received from our Registrar and Transfer Agent - Link Intime India Private Limited, which is enclosed herewith.
30-01-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from the shareholder about loss of share certificates on January 25, 2023
26-01-2023
Bigul

Fermenta Biotech Ltd - 506414 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received an intimation from its Registrar and Transfer Agent - Link Intime India Private Limited on January 17, 2023 regarding issue of duplicate share certificate to the shareholder.
18-01-2023
Bigul

Fermenta Biotech Ltd - 506414 - Execution Of Sale Deed

 Further to our earlier intimation dated June 9, 2022 in relation to the members' approval obtained to sell, lease, or otherwise dispose of the portion of Company's assets being premises located in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610, we wish to inform you that the Company has executed and registered a sale deed on January 17, 2023 to sell premises situated at the 7th floor in Thane One Building, DIL Complex, Ghodbunder Road, Majiwade, Thane (West) 400 610 on the terms and conditions mentioned in the sale deed and as approved by the Board of Directors of the Company. The information regarding the aforesaid sale of premises is provided in Annex-'A' herewith. This intimation is given under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 for your records.
17-01-2023
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that a joint petition under Sections 230 to 232 of the Companies Act, 2013, for sanction of the Composite Scheme of Amalgamation and Arrangement amongst DVK Investments Private Limited ('DVK' or 'Transferor Company 1') and Aegean Properties Limited ('APL' or 'Transferor Company 2') and Fermenta Biotech Limited and their respective Shareholders was presented by the Company, on September 9, 2022, and the said petition was admitted on December 21, 2022. The petition is fixed for hearing by NCLT on February 24, 2023. As per direction of the NCLT, the Notice of hearing was published in 'Business Standard' (in English Language) having nation-wide circulation and 'Navshakti' (in Marathi Language) having circulation in the State of Maharashtra on January 9, 2023.
10-01-2023
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company''s Code of Conduct for Prevention of Insider Trading and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, it is hereby notified that the 'Trading Window' i.e. period for trading in Company's securities, will be closed with effect from January 01, 2023 till 48 hours after the declaration of financial results for the quarter and nine months ended December 31, 2022, as may be approved at the concerned Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be announced in due course.
29-12-2022
Next Page
Close

Let's Open Free Demat Account